Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis.
about
Childhood Body Size and the Risk of Malignant Melanoma in AdulthoodTranscriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulationHmga2 translocation induced in skin tumorigenesis.Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons.Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathwayStress from Nucleotide Depletion Activates the Transcriptional Regulator HEXIM1 to Suppress Melanoma.Established and Emerging Biomarkers in Cutaneous Malignant Melanoma.Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.CD271 determines migratory properties of melanoma cells.Integrative network and transcriptomics-based approach predicts genotype- specific drug combinations for melanoma.Amplified HMGA2 promotes cell growth by regulating Akt pathway in AML.High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification.Microarray Analysis of Differentially-Expressed Genes Encoding CYP450 and Phase II Drug Metabolizing Enzymes in Psoriasis and Melanoma.NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma.HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma.BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer.Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach.Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability.Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene.High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis.A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis.Network-Based Identification of Altered Stem Cell Pluripotency and Calcium Signaling Pathways in Metastatic Melanoma.Extracting Fitness Relationships and Oncogenic Patterns among Driver Genes in Cancer.The fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation in melanoma cells.A meta-analysis of transcriptome datasets characterizes malignant transformation from melanocytes and nevi to melanoma.Loss of GCNT2/I-branched glycans enhances melanoma growth and survivalHmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
P2860
Q33571911-436F393D-831C-4B7A-B315-DD0B804CA8CEQ33631126-6258D2F0-E8C9-4960-8581-676A4F90FFA1Q33728215-C385E34B-AE96-478F-B189-93AAD77C627AQ35900481-5B2A5540-62BE-4F51-9628-61C249710614Q36009638-72E61FF6-4A37-458F-8AD7-05D7A84E8A69Q36287435-0D29697C-55C3-4128-A573-EFDAD015462FQ36513525-15F12647-65B5-4604-8678-F15890A4F085Q36811094-A774D8E7-8001-4689-A59B-44B8BC549D8AQ37069223-1AAC43BA-8925-4136-8D0F-EFFBED2D5555Q37702372-61808C18-BB0C-437E-AFC8-42094F300F97Q38603000-7DD312C4-4897-4CC0-9BA0-550EF9D2450BQ38621140-759B2332-8578-4630-A48A-A1702B953EFCQ38839711-C5945130-4A9B-4309-97BB-92A1E1F66F2DQ38852100-3F424F26-250C-4B68-A0F8-DC84A5666568Q38903238-DB6D74B7-86C1-4254-9EAD-94FEAAE91D92Q39582357-ACF7C2E7-8293-4A81-80AD-6AB7DB27DDACQ40961149-652B1EB7-7060-49FE-8AF4-434B3B821B90Q41816648-4B1DA5FF-46B5-4057-9133-74406B21EC15Q44937688-650A1498-7B15-4CD1-A986-5CE2F04B2800Q45943042-0F1A7937-4F5A-445F-A824-84E9F894E735Q47304492-1C319787-6700-456C-8805-1FD069DA7291Q47391313-3C56ABA8-569B-4A72-8726-1535A1160893Q49288145-328865B3-AE34-48A9-B302-549F4D06BC1DQ50946912-F93FF799-F9C4-4A75-9EBB-CEA1CB7C889BQ52666846-F7D0FFFC-A219-4AF9-AB85-6FD42DD9576FQ52731993-3E6D00C1-A5F6-4674-9A54-1796200D71BBQ55490842-D28D62A2-456F-4373-86BE-2673AF6A08F4Q55640224-A54410B3-67F1-4006-8D1B-8DC56FD5FF62Q58721942-C4B00FD7-30C0-4DF6-AF8E-3CB8FA3B90CFQ58726181-0AE0AD03-59F9-4AD9-B816-BBC8DEF723A9
P2860
Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Transcriptome profiling identi ...... oma progression and prognosis.
@ast
Transcriptome profiling identi ...... oma progression and prognosis.
@en
Transcriptome profiling identi ...... oma progression and prognosis.
@nl
type
label
Transcriptome profiling identi ...... oma progression and prognosis.
@ast
Transcriptome profiling identi ...... oma progression and prognosis.
@en
Transcriptome profiling identi ...... oma progression and prognosis.
@nl
prefLabel
Transcriptome profiling identi ...... oma progression and prognosis.
@ast
Transcriptome profiling identi ...... oma progression and prognosis.
@en
Transcriptome profiling identi ...... oma progression and prognosis.
@nl
P2093
P2860
P356
P1476
Transcriptome profiling identi ...... oma progression and prognosis.
@en
P2093
Bhramar Mukherjee
Dafydd G Thomas
Douglas R Fullen
Kelly B Cha
Marcus L Frohm
Stephen B Gruber
Timothy M Johnson
P2860
P2888
P304
P356
10.1038/JID.2013.197
P407
P577
2013-04-30T00:00:00Z
P5875
P6179
1007979822